Literature DB >> 2808681

Immunoblot analysis of serum immunoglobulin G response to surface proteins of Clostridium difficile in patients with antibiotic-associated diarrhea.

A Pantosti1, M Cerquetti, F Viti, G Ortisi, P Mastrantonio.   

Abstract

We examined by immunoblot analysis the serum immunoglobulin G antibody response to EDTA-extracted surface proteins of Clostridium difficile in 16 patients with antibiotic-associated diarrhea. For each patient, paired serum samples were tested against proteins of the infecting strain and of a collection strain (C253) known to belong to the electrophoretic group 2 pattern. Eight patients, all harboring group 2 C. difficile strains, exhibited responses to the proteins of the infecting strain; six patients showed increases in the level of antibodies between acute-phase and convalescent-phase sera. A great variability in the antigens recognized was found; however, seven patients possessed antibodies directed against an antigen of about 35 kilodaltons, corresponding to the major protein of group 2 strains. The sera of these seven patients cross-reacted also with the 35-kilodalton and other proteins of strain C253. Our data show that C. difficile proteins other than toxins can elicit an immune response in patients with C. difficile-associated disease; in this group of patients, the major surface protein of the group 2 strains was the antigen most often recognized.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808681      PMCID: PMC267082          DOI: 10.1128/jcm.27.11.2594-2597.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile.

Authors:  S R Heard; B Rasburn; R C Matthews; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions.

Authors:  A Pantosti; M Cerquetti; P M Gianfrilli
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Antitoxin production in antibiotic-associated colitis?

Authors:  A H Lishman; I J Al-Jumaili; C O Record
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

4.  Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  J Immunol Methods       Date:  1983-06-10       Impact factor: 2.303

5.  Serum antibody response to toxins A and B of Clostridium difficile.

Authors:  R Viscidi; B E Laughon; R Yolken; P Bo-Linn; T Moench; R W Ryder; J G Bartlett
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

6.  Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains.

Authors:  S P Borriello; F E Barclay
Journal:  J Med Microbiol       Date:  1985-06       Impact factor: 2.472

Review 7.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

8.  Serotyping of Clostridium difficile.

Authors:  S Toma; G Lesiak; M Magus; H L Lo; M Delmée
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

9.  Cytotoxin and enterotoxin production by Clostridium difficile.

Authors:  P Gianfrilli; I Luzzi; A Pantosti; M Occhionero; G Gentile; G Panichi
Journal:  Microbiologica       Date:  1984-10

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more
  9 in total

1.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  A molecular characterization of Clostridium difficile isolates from humans, animals and their environments.

Authors:  G O'Neill; J E Adams; R A Bowman; T V Riley
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

3.  Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.

Authors:  Patrizia Spigaglia; Fabrizio Barbanti; Paola Mastrantonio
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

4.  Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Authors:  Hiba Kandalaft; Greg Hussack; Annie Aubry; Henk van Faassen; Yonghong Guan; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; Susan M Logan; Jamshid Tanha
Journal:  Appl Microbiol Biotechnol       Date:  2015-05-05       Impact factor: 4.813

Review 5.  Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

Authors:  Séverine Péchiné; Jean F Bruxelle; Claire Janoir; Anne Collignon
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

6.  Mapping Epitopes of a Novel Peptidoglycan Cross-Linking Enzyme Cwp22 Recognized by Human Sera Obtained from Patients with Clostridioides difficile Infection and Cord Blood.

Authors:  Agnieszka Razim; Katarzyna Pacyga; Gajane Martirosian; Andrzej Szuba; Andrzej Gamian; Andrzej Myc; Sabina Górska
Journal:  Microorganisms       Date:  2019-11-14

7.  Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.

Authors:  N Jan; R A Hays; D N Oakland; P Kumar; G Ramakrishnan; B W Behm; W A Petri; C Marie
Journal:  mSphere       Date:  2021-10-27       Impact factor: 4.389

8.  A Case Report and Review of the Literature: Reactive Arthritis Caused by Clostridioides difficile ribotype 027.

Authors:  Ortrud Zimmermann; Heinrich Köchel; Wolfgang Bohne; Beatrix Pollok-Kopp; Peter Passenberg; Uwe Groß
Journal:  Front Microbiol       Date:  2022-02-16       Impact factor: 5.640

9.  The Bioinformatic and In Vitro Studies of Clostridioides Difficile Aminopeptidase M24 Revealed the Immunoreactive KKGIK Peptide.

Authors:  Katarzyna Pacyga; Agnieszka Razim; Gayane Martirosian; Małgorzata Aptekorz; Andrzej Szuba; Andrzej Gamian; Andrzej Myc; Sabina Górska
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.